The Underutilization of COVID-19 and Flu Antivirals

The introduction of COVID-19 and influenza (flu) antivirals marked a significant advancement in the battle against two potentially life-threatening viral respiratory diseases. However, despite their proven benefits, data suggest a concerning gap between the need for these treatments and prescription rates, particularly among high-risk and underserved communities.